4.6 Article

COVID-19-specific transcriptomic signature detectable in blood across multiple cohorts

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Letter Critical Care Medicine

Cyclosporin A Reveals Potent Antiviral Effects in Preclinical Models of SARS-CoV-2 Infection

Lucie Sauerhering et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Review Biochemistry & Molecular Biology

Theophylline: Old Drug in a New Light, Application in COVID-19 through Computational Studies

Luis M. Montano et al.

Summary: Theophylline is a potential adjuvant in the treatment of COVID-19 patients, as it down-regulates the inflammatory processes activated by the virus through various mechanisms. Computational simulation studies have been used to explore its applications and effects.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Health Care Sciences & Services

High Angiotensin-Converting Enzyme and Low Carboxypeptidase N Serum Activity Correlate with Disease Severity in COVID-19 Patients

Phil-Robin Tepasse et al.

Summary: This study found that serum protease activity in COVID-19 patients is associated with disease severity, indicating the involvement of the renin-angiotensin system (RAS) and angiotensin-converting enzyme (ACE) as a potential therapeutic target. Further dedicated studies are needed to confirm these findings.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Article Biochemistry & Molecular Biology

Large-Scale Multi-omic Analysis of COVID-19 Severity

Katherine A. Overmyer et al.

Summary: The study conducted RNA-seq and high-resolution mass spectrometry on blood samples from COVID-19-positive and COVID-19-negative patients, identifying molecular features associated with disease severity and outcomes, offering pathophysiological insights and therapeutic suggestions. The observed dysregulation of platelet function, blood coagulation, acute phase response, and endotheliopathy further illuminated the unique COVID-19 phenotype. The findings are presented through a web-based tool enabling interactive exploration and machine learning prediction of COVID-19 severity.

CELL SYSTEMS (2021)

Review Biochemistry & Molecular Biology

The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved

Francesca Coperchini et al.

Summary: The cytokine/chemokine network plays a crucial role in the cytokine storm of COVID-19, with chemokines being identified as important factors for individual risk stratification and predicting the clinical course of the disease. Studying the involvement of chemokines in COVID-19 will provide insights into the complex physiopathology of the cytokine storm.

CYTOKINE & GROWTH FACTOR REVIEWS (2021)

News Item Multidisciplinary Sciences

ROGUE ANTIBODIES COULD BE DRIVING SEVERE COVID-19

Roxanne Khamsi

Summary: Evidence suggests that self-attacking autoantibodies may be crucial in understanding some of the most severe cases of SARS-CoV-2 infection.

NATURE (2021)

Article Multidisciplinary Sciences

Global absence and targeting of protective immune states in severe COVID-19

Alexis J. Combes et al.

Summary: Patients with mild COVID-19 exhibit a coordinated pattern of expression of interferon-stimulated genes (ISGs) across every cell population, whereas these ISG-expressing cells are systemically absent in patients with severe disease. Individuals with severe COVID-19 produce very high titres of anti-SARS-CoV-2 antibodies and have a lower viral load compared to individuals with mild disease.

NATURE (2021)

Article Immunology

Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19

Enrico Brunetta et al.

Summary: In patients with severe COVID-19, elevated levels of long pentraxin PTX3 have been found to be a strong predictor of decreased survival. Myelomonocytic cells and endothelial cells in both blood and lung tissue are major sources of PTX3, with PTX3 plasma concentration serving as an independent prognostic indicator for short-term mortality in COVID-19 patients.

NATURE IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

Chemokines and chemokine receptors during COVID-19 infection

Bariaa A. Khalil et al.

Summary: Chemokines play a crucial role in the immune response by clearing pathogens, but their excessive release can lead to hyperinflammation and severe complications. In COVID-19, chemokines may directly cause acute respiratory distress syndrome, increasing the risk of death. Understanding the role of chemokines in COVID-19 pathogenesis is important for developing potential therapeutic targets.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Article Biochemistry & Molecular Biology

Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19

Can Liu et al.

Summary: This study longitudinally assessed various factors in single peripheral immune cells of COVID-19 patients and identified primary correlates of disease severity and outcome. Timing was emphasized as crucial in the analysis, clinical monitoring, and therapeutic intervention of COVID-19.
Article Biochemistry & Molecular Biology

Comparison of Antiviral Activity of Gemcitabine with 2′-Fluoro-2′-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2

Yejin Jang et al.

Summary: The study found that gemcitabine has high antiviral activity against SARS-CoV-2, while 2FdC has lower antiviral activity. Both compounds showed low cytotoxicity towards cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Multidisciplinary Sciences

Dysregulated transcriptional responses to SARS-CoV-2 in the periphery

Micah T. McClain et al.

Summary: In this study, McClain et al. used RNA sequencing to compare the peripheral blood transcriptome of subjects with SARS-CoV-2 and other respiratory infections. They found dysregulated immune responses in COVID-19 with both heterogeneous and conserved components.

NATURE COMMUNICATIONS (2021)

Article Biochemistry & Molecular Biology

COVID-19 induces a hyperactive phenotype in circulating platelets

Shane P. Comer et al.

Summary: This study found distinct differences in routine full blood count and other clinical laboratory parameters between patients with severe and nonsevere COVID-19. It also determined that all COVID-19 patients possess hyperactive circulating platelets, suggesting abnormal platelet reactivity may contribute to hypercoagulability in COVID-19, influencing the severity of the disease and recovery path complexity.

PLOS BIOLOGY (2021)

Review Pharmacology & Pharmacy

Chemokine Regulation During Epidemic Coronavirus Infection

Shamik Majumdar et al.

Summary: SARS-CoV-2 is the third coronavirus causing severe pneumonia epidemics in humans, and the immune response to coronavirus infection can have both protective and harmful effects. Chemokines and chemokine receptors play crucial roles in coordinating immune responses during infection with epidemic coronaviruses, and they may serve as important biomarkers and therapeutic targets.

FRONTIERS IN PHARMACOLOGY (2021)

Article Immunology

High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China

Wei Cao et al.

Summary: This study suggests that high-dose IVIg administered to severe COVID-19 patients within 14 days of onset is associated with reduced 28-day mortality, particularly in those without comorbidities or treated early in the disease course.

FRONTIERS IN IMMUNOLOGY (2021)

Article Public, Environmental & Occupational Health

Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents

Mohammad Z. Ahmed et al.

Summary: The study suggests that aminoglycosides may be effective drugs to combat COVID-19. Amikacin was identified as the most potent inhibitor of M-pro, forming a stable complex with M-pro through hydrogen bonds, salt bridges, and van der Waals interactions. Further validation through in vitro and in vivo studies is required before aminoglycosides can be used as an anti-COVID-19 agent.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2021)

Article Multidisciplinary Sciences

A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood

Dianna L. Ng et al.

Summary: RNA sequencing analysis showed a muted immune response in COVID-19 patients, with differences in pathological responses between hospitalized and outpatient patients. Machine learning can aid in the accurate identification of COVID-19 disease.

SCIENCE ADVANCES (2021)

Article Hematology

A neutrophil activation signature predicts critical illness and mortality in COVID-19

Matthew L. Meizlish et al.

Summary: Pathologic immune hyperactivation, particularly neutrophil activation, plays a central role in severe COVID-19, with early markers predicting clinical decompensation and higher mortality rates. These findings highlight the importance of understanding immune responses in critically ill COVID-19 patients.

BLOOD ADVANCES (2021)

Article Pathology

Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host Mediators

Michael O'Hare et al.

Summary: This study showed that inhibition of RUNX1 with Ro24-7429 significantly ameliorates lung fibrosis and inflammation in a mouse model. The inhibition of RUNX1 not only blunted the traditional mechanisms of fibrosis and inflammation, but also reduced the expression of key host proteins associated with SARS-CoV-2 infection.

AMERICAN JOURNAL OF PATHOLOGY (2021)

Article Respiratory System

Pentoxifylline or theophylline use in hospitalized COVID-19 patients requiring oxygen support

Geoffrey C. Wall et al.

Summary: In this retrospective study of 209 hospitalized COVID-19 patients, theophylline and pentoxifylline treatment was associated with an increase in ROX score, a decrease in CRP levels, and a lower mortality rate compared to the standard treatment group. The findings suggest a potential efficacy and safety of these drugs in COVID-19 pneumonia patients, warranting further exploration through randomized controlled trials.

CLINICAL RESPIRATORY JOURNAL (2021)

Article Infectious Diseases

The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients

Veronica Bordoni et al.

Summary: The dysregulated inflammatory profile and depletion of lymphocytes in COVID-19 patients are associated with higher p53 expression, lower SIRT1 expression, and decreased expression of IL7R and BLNK. These factors may impact cell survival, B cell signaling, and antibody production.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

In silico analysis suggests the RNAi-enhancing antibiotic enoxacin as a potential inhibitor of SARS-CoV-2 infection

Amirhossein Ahmadi et al.

Summary: COVID-19 is the biggest challenge in the world currently, with no specific medicine available. Recent studies suggest that enoxacin may have anti-SARS-CoV-2 effects by enhancing the RNAi pathway, making it a promising candidate for COVID-19 treatment.

SCIENTIFIC REPORTS (2021)

Article Immunology

Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease

Toshiyuki Kitoh et al.

Summary: PTX3 is a reliable biomarker for predicting IVIG resistance and subsequent CAL formation in patients with KD, with a specificity of 88.5% and a sensitivity of 94.4%.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

How to Train Your Dragon: Harnessing Gamma Delta T Cells Antiviral Functions and Trained Immunity in a Pandemic Era

Jonathan Caron et al.

Summary: Emerging evidence suggests that gamma delta T cells play a crucial role in the immune response to viral infections by detecting viruses early and triggering antiviral functions. Activating the antiviral potential of gamma delta T cells could be harnessed to prevent or treat viral infections effectively.

FRONTIERS IN IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Integrated analysis of multimodal single-cell data

Yuhan Hao et al.

Summary: The study introduces a weighted-nearest neighbor analysis framework to learn the relative utility of each data type in each cell, enabling integrative analysis of multiple modalities. Applied to a CITE-seq dataset, the method constructs a multimodal reference atlas of the circulating immune system and successfully identifies and validates previously unreported lymphoid subpopulations.
Article Multidisciplinary Sciences

Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein

Jack Chun-Chieh Hsu et al.

Summary: SARS-CoV-2 shuts down host innate immune responses through the translation inhibition activity of NSP14, revealing insights into the pathogenesis of the virus.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Immunology

Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients

Stephanie Bibert et al.

Summary: The dysregulated immunity in COVID-19 patients plays a key role in the severity of the disease, including defects in IFN responses, reduced toxicity-related molecules in NK cells, and increased neutrophil degranulation. Additionally, differences in gene expression patterns are also determinants of COVID-19 severity.

FRONTIERS IN IMMUNOLOGY (2021)

Review Medicine, General & Internal

Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19?

Christian A. Devaux et al.

Summary: Cyclosporin A (CsA) has shown potential therapeutic effects against COVID-19 through multiple mechanisms such as anti-inflammatory, antiviral, and antagonistic actions against angiotensin II. Preliminary clinical trials on COVID-19 patients indicate a lower mortality rate with CsA, suggesting further investigation is warranted to determine its potential as a first-line therapy for COVID-19.

FRONTIERS IN MEDICINE (2021)

Article Medicine, General & Internal

Unprovoked serotonin syndrome-like presentation of SARS-CoV-2 infection: A small case series

Philip Keith et al.

Summary: Clinicians and researchers have reported various neurological abnormalities in COVID-19, including cases resembling serotonin syndrome. However, there have been no reports of central nervous system serotonin toxicity in COVID-19. These two cases highlight the importance of considering and recognizing unique presentations in COVID-19, requiring a high index of suspicion.

SAGE OPEN MEDICAL CASE REPORTS (2021)

Article Biochemistry & Molecular Biology

Rapid isolation and immune profiling of SARS-CoV-2 specific memory B cell in convalescent COVID-19 patients via LIBRA-seq

Bing He et al.

Summary: This study revealed the frequency, diversity, and specificity of antibody immune responses following SARS-CoV-2 infection using the LIBRA-seq technology. The results showed that a specific memory B cell subgroup in convalescent COVID-19 patients had a higher proportion of SARS-CoV-2 antigen-labeled cells, and public antibody clonotypes were shared by distinct individuals. Additionally, antibodies isolated by LIBRA-seq exhibited high binding affinity and neutralizing activities against SARS-CoV-2.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Respiratory System

Use of Intravenous Immunoglobulin (Prevagen or Octagam) for the Treatment of COVID-19: Retrospective Case Series

Felix J. F. Herth et al.

Summary: This study retrospectively evaluated the clinical courses of 12 COVID-19 patients who received IVIG treatment, showing that IVIG may improve the clinical state of patients with moderate to severe COVID-19 infection. Despite high illness severity scores, all patients survived hospital discharge.

RESPIRATION (2021)

Editorial Material Medicine, General & Internal

Treatment of Community-Acquired Pneumonia During the Coronavirus Disease 2019 (COVID-19) Pandemic

Joshua P. Metlay et al.

ANNALS OF INTERNAL MEDICINE (2020)

Article Microbiology

A Dynamic Immune Response Shapes COVID-19 Progression

Eugenia Ziying Ong et al.

CELL HOST & MICROBE (2020)

Editorial Material Medicine, Research & Experimental

SARS-CoV-2: a storm is raging

Savannah F. Pedersen et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Cardiac & Cardiovascular Systems

COVID-19 update: Covid-19-associated coagulopathy

Richard C. Becker

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)

Article Immunology

Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture

Ya-Nan Zhang et al.

EMERGING MICROBES & INFECTIONS (2020)

Article Medicine, General & Internal

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Editorial Material Medicine, Research & Experimental

Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19?

Irene Karampela et al.

ARCHIVES OF MEDICAL RESEARCH (2020)

Article Hematology

Platelet gene expression and function in patients with COVID-19

Bhanu Kanth Manne et al.

Article Biochemistry & Molecular Biology

The Global Phosphorylation Landscape of SARS-CoV-2 Infection

Mehdi Bouhaddou et al.

Review Biochemistry & Molecular Biology

Targeting Eukaryotic mRNA Translation byLegionella pneumophila

Yury Belyi

FRONTIERS IN MOLECULAR BIOSCIENCES (2020)

Review Critical Care Medicine

Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis

Ian Huang et al.

JOURNAL OF INTENSIVE CARE (2020)

Article Infectious Diseases

Estimates of the severity of coronavirus disease 2019: a model-based analysis

Robert Verity et al.

LANCET INFECTIOUS DISEASES (2020)

Article Biochemistry & Molecular Biology

SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses

Abhik K. Banerjee et al.

Article Immunology

Single-cell landscape of immunological responses in patients with COVID-19

Ji-Yuan Zhang et al.

NATURE IMMUNOLOGY (2020)

Article Biochemistry & Molecular Biology

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

Aaron J. Wilk et al.

NATURE MEDICINE (2020)

Article Pharmacology & Pharmacy

Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis

Krzysztof Marciniec et al.

PHARMACOLOGICAL REPORTS (2020)

Article Multidisciplinary Sciences

Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans

Prabhu S. Arunachalam et al.

SCIENCE (2020)

Article Biochemical Research Methods

Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2

Manisha Prajapat et al.

JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2020)

Review Veterinary Sciences

A Mini-Review on Cell Cycle Regulation of Coronavirus Infection

Mingjun Su et al.

FRONTIERS IN VETERINARY SCIENCE (2020)

Article Medicine, Research & Experimental

COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain

Massimiliano Secchi et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Multidisciplinary Sciences

Metascape provides a biologist-oriented resource for the analysis of systems-level datasets

Yingyao Zhou et al.

NATURE COMMUNICATIONS (2019)

Review Immunology

Misunderstandings Between Platelets and Neutrophils Build in Chronic Inflammation

Giuseppe A. Ramirez et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Pharmacology & Pharmacy

Mitochondrial Permeability Transition: A Molecular Lesion with Multiple Drug Targets

Thomas Briston et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2019)

Review Cardiac & Cardiovascular Systems

Platelet-Neutrophil Interplay: Insights Into Neutrophil Extracellular Trap (NET)-Driven Coagulation in Infection

Amanda Z. Zucoloto et al.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2019)

Article Biochemistry & Molecular Biology

Database resources of the National Center for Biotechnology Information

Richa Agarwala et al.

NUCLEIC ACIDS RESEARCH (2018)

Article Biochemical Research Methods

ROTS: An R package for reproducibility-optimized statistical testing

Tomi Suomi et al.

PLOS COMPUTATIONAL BIOLOGY (2017)

Article Biochemistry & Molecular Biology

ROTS: reproducible RNA-seq biomarker detector-prognostic markers for clear cell renal cell cancer

Fatemeh Seyednasrollah et al.

NUCLEIC ACIDS RESEARCH (2016)

Article Biology

A systematic view on influenza induced host shutoff

Adi Bercovich-Kinori et al.

Article Multidisciplinary Sciences

HIV-1 Infection Causes a Down-Regulation of Genes Involved in Ribosome Biogenesis

Claudia L. Kleinman et al.

PLOS ONE (2014)

Article Medicine, Research & Experimental

Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes

Joanna M. Warszawska et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Article Cardiac & Cardiovascular Systems

Aspirin Exposure Reveals Novel Genes Associated With Platelet Function and Cardiovascular Events

Deepak Voora et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)

Meeting Abstract Cardiac & Cardiovascular Systems

PTX3, A NEW BIOMARKER FOR VASCULITIS, PREDICTS INTRAVENOUS IMMUNOGLOBULIN UNRESPONSIVENESS IN PATIENTS WITH KAWASAKI DISEASE

Yasuhiro Katsube et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)

Article Immunology

Regulation of leukocyte recruitment by the long pentraxin PTX3

Livija Deban et al.

NATURE IMMUNOLOGY (2010)

Article Biochemistry & Molecular Biology

Reactome knowledgebase of human biological pathways and processes

Lisa Matthews et al.

NUCLEIC ACIDS RESEARCH (2009)

Letter Cell Biology

Enhancement of RNAi by a small molecule antibiotic enoxacin

Qiangzhe Zhang et al.

CELL RESEARCH (2008)

Article Medicine, General & Internal

Shared and Distinct Genetic Variants in Type 1 Diabetes and Celiac Disease

Deborah J. Smyth et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Cardiac & Cardiovascular Systems

GRO family chemokines are specialized for monocyte arrest from flow

DF Smith et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)

Article Medicine, Research & Experimental

Regulation of inherently autoreactive VH4-34B cells in the maintenance of human B cell tolerance

AE Pugh-Bernard et al.

JOURNAL OF CLINICAL INVESTIGATION (2001)

Article Hematology

RUNX1/AML1: A central player in hematopoiesis

T Okuda et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2001)